{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:11:13Z","timestamp":1790838673531,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373325"],"award-info":[{"award-number":["81373325"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673357"],"award-info":[{"award-number":["81673357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400825"],"award-info":[{"award-number":["81400825"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21602222"],"award-info":[{"award-number":["21602222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Province","award":["2016A050502035"],"award-info":[{"award-number":["2016A050502035"]}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDA12020315"],"award-info":[{"award-number":["XDA12020315"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDA12020363"],"award-info":[{"award-number":["XDA12020363"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese National Programs for Key Research and Development","award":["2016YFB0201701"],"award-info":[{"award-number":["2016YFB0201701"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2015A030312014"],"award-info":[{"award-number":["2015A030312014"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangzhou Healthcare Collaborative Innovation Programs","award":["201508020255"],"award-info":[{"award-number":["201508020255"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejmech.2018.01.087","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T00:17:11Z","timestamp":1517962631000},"page":"238-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Discovery and optimization of 1-(1 H -indol-1-yl)ethanone derivatives as CBP\/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer"],"prefix":"10.1016","volume":"147","author":[{"given":"Qiuping","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff B.","family":"Smaill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam V.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3601-0246","authenticated-orcid":false,"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.01.087_bib1","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.ejmech.2018.01.087_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2018.01.087_bib3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature13229","article-title":"Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer","volume":"510","author":"Asangani","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.01.087_bib4","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1093\/nar\/gkv262","article-title":"Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies","volume":"43","author":"Chan","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2018.01.087_bib5","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.18632\/oncotarget.1572","article-title":"Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer","volume":"4","author":"Wyce","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2018.01.087_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ccr.2010.04.027","article-title":"Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor","volume":"17","author":"Andersen","year":"2010","journal-title":"Canc. Cell"},{"key":"10.1016\/j.ejmech.2018.01.087_bib7","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.18632\/oncotarget.2924","article-title":"EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer","volume":"6","author":"Brand","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2018.01.087_bib8","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1172\/JCI66398","article-title":"An androgen receptor N-terminal domain antagonist for treating prostate cancer","volume":"123","author":"Myung","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2018.01.087_bib9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.4070","article-title":"ROR-gamma drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer","volume":"22","author":"Wang","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2018.01.087_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejmech.2014.03.065","article-title":"Discovery of 2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide derivatives as new RORgamma inhibitors using virtual screening, synthesis and biological evaluation","volume":"78","author":"Zhang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.087_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/383099a0","article-title":"Role of CBP\/P300 in nuclear receptor signalling","volume":"383","author":"Chakravarti","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.01.087_bib12","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1242\/jcs.114.13.2363","article-title":"p300\/CBP proteins: HATs for transcriptional bridges and scaffolds","volume":"114","author":"Chan","year":"2001","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ejmech.2018.01.087_bib13","doi-asserted-by":"crossref","first-page":"31853","DOI":"10.1074\/jbc.273.48.31853","article-title":"CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1","volume":"273","author":"Fronsdal","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.01.087_bib14","doi-asserted-by":"crossref","first-page":"11540","DOI":"10.1073\/pnas.93.21.11540","article-title":"p300 is a component of an estrogen receptor coactivator complex","volume":"93","author":"Hanstein","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2018.01.087_bib15","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1073\/pnas.92.12.5451","article-title":"Involvement of the cell-cycle inhibitor Cip1\/WAF1 and the E1A-associated p300 protein in terminal differentiation","volume":"92","author":"Missero","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2018.01.087_bib16","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.chembiol.2015.10.013","article-title":"Transcriptional profiling of a selective CREB binding protein bromodomain inhibitor highlights therapeutic opportunities","volume":"22","author":"Chekler","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.01.087_bib17","article-title":"Bromodomain inhibition of the transcriptional coactivators CBP\/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma","volume":"5","author":"Conery","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2018.01.087_bib18","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.1128\/MCB.25.23.10220-10234.2005","article-title":"Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription","volume":"25","author":"Faiola","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.01.087_bib19","doi-asserted-by":"crossref","first-page":"13014","DOI":"10.1074\/jbc.M115.708560","article-title":"Regulatory T cell modulation by CBP\/EP300 bromodomain inhibition","volume":"291","author":"Ghosh","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.01.087_bib20","doi-asserted-by":"crossref","first-page":"9308","DOI":"10.1021\/ja412434f","article-title":"Discovery and optimization of small-molecule ligands for the CBP\/p300 bromodomains","volume":"136","author":"Hay","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.01.087_bib21","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1074\/jbc.M111.300194","article-title":"Selective roles for cAMP response element-binding protein binding protein and p300 protein as coregulators for androgen-regulated gene expression in advanced prostate cancer cells","volume":"287","author":"Ianculescu","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.01.087_bib22","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1038\/sj.onc.1207118","article-title":"p300\/CBP and cancer","volume":"23","author":"Iyer","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.01.087_bib23","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1007\/s00018-012-1254-4","article-title":"Transcriptional\/epigenetic regulator CBP\/p300 in tumorigenesis: structural and functional versatility in target recognition","volume":"70","author":"Wang","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2018.01.087_bib24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/pros.21257","article-title":"Transcriptional coactivators p300 and CBP stimulate estrogen receptor-beta signaling and regulate cellular events in prostate cancer","volume":"71","author":"Bouchal","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.ejmech.2018.01.087_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.chembiol.2005.10.014","article-title":"Target structure-based discovery of small molecules that block human p53 and CREB binding protein association","volume":"13","author":"Sachchidanand","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.01.087_bib26","doi-asserted-by":"crossref","first-page":"10549","DOI":"10.1021\/acs.jmedchem.6b01022","article-title":"Discovery of a potent and selective in\u00a0vivo probe (GNE-272) for the bromodomains of CBP\/EP300","volume":"59","author":"Crawford","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.087_bib27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/jm401568s","article-title":"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains","volume":"57","author":"Fedorov","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.087_bib28","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1158\/0008-5472.CAN-15-0236","article-title":"Generation of a selective small molecule inhibitor of the CBP\/p300 bromodomain for leukemia therapy","volume":"75","author":"Picaud","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2018.01.087_bib29","doi-asserted-by":"crossref","first-page":"8889","DOI":"10.1021\/acs.jmedchem.6b00774","article-title":"Development of selective CBP\/P300 benzoxazepine bromodomain inhibitors","volume":"59","author":"Popp","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.087_bib30","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1002\/anie.201402750","article-title":"A\u00a0series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-pi interaction","volume":"53","author":"Rooney","year":"2014","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2018.01.087_bib31","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11156","article-title":"Salicylate, diflunisal and their metabolites inhibit CBP\/p300 and exhibit anticancer activity","volume":"5","author":"Shirakawa","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2018.01.087_bib32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/acsmedchemlett.6b00075","article-title":"Fragment-based discovery of a selective and cell-active benzodiazepinone CBP\/EP300 bromodomain inhibitor (CPI-637)","volume":"7","author":"Taylor","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.01.087_bib33","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1021\/acs.jmedchem.5b00172","article-title":"Fragment-based design of selective nanomolar ligands of the CREBBP bromodomain","volume":"59","author":"Unzue","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.087_bib34","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1021\/acs.jmedchem.5b01757","article-title":"The \u201cGatekeeper\u201d residue influences the mode of binding of acetyl indoles to bromodomains","volume":"59","author":"Unzue","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.087_bib35","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1021\/acs.jmedchem.5b00171","article-title":"Discovery of CREBBP bromodomain inhibitors by high-throughput docking and hit optimization guided by molecular dynamics","volume":"59","author":"Xu","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.087_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejmech.2016.03.052","article-title":"Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORgamma inverse agonists: virtual screening, structure-based optimization, and biological evaluation","volume":"116","author":"Song","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.087_bib37","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/acs.jmedchem.5b01511","article-title":"Discovery of benzo[cd]indol-2(1H)-ones as potent and specific BET bromodomain inhibitors: structure-based virtual screening, optimization, and biological evaluation","volume":"59","author":"Xue","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.087_bib38","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1016\/j.bmc.2016.07.022","article-title":"The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biological evaluation","volume":"24","author":"Zhou","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.087_bib39","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/onc.2013.169","article-title":"Small-molecule inhibition of CBP\/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia","volume":"33","author":"Gang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.01.087_bib40","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1021\/acs.biochem.6b00480","article-title":"Modulation of p300\/CBP acetylation of nucleosomes by bromodomain ligand I-CBP112","volume":"55","author":"Zucconi","year":"2016","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.ejmech.2018.01.087_bib41","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/157340612801216283","article-title":"Prodrug strategies in ocular drug delivery","volume":"8","author":"Barot","year":"2012","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.087_bib42","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1124\/pr.110.003459","article-title":"Prodrugs\u2013from serendipity to rational design","volume":"63","author":"Huttunen","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2018.01.087_bib43","first-page":"41","article-title":"Processging diffraction data with mosflm","volume":"245","author":"Leslie","year":"2007","journal-title":"Evol. Dev."},{"key":"10.1016\/j.ejmech.2018.01.087_bib44","first-page":"760","article-title":"The CCP4 suite: programs for protein crystallography","volume":"50","year":"2007","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2018.01.087_bib45","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2018.01.087_bib46","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2018.01.087_bib47","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2018.01.087_bib48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2018.01.087_bib49","series-title":"The PyMOL Molecular Graphics System","author":"DeLano","year":"2002"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418301090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418301090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T00:14:41Z","timestamp":1660436081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418301090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":49,"alternative-id":["S0223523418301090"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.087","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP\/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}